ArticlePharmaceuticals (Basel, Switzerland)2025

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib.

Rima Hajjo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.